Search Results

BERKY consists of a membrane linker, a BRET donor, an ER/K α-helix linker, a BRET acceptor, and an active

act as dynamic pharmacological entities Marina Casiraghi, Robert J Lefkowitz, Peter Gmeiner, Brian K

full control of signaling activity through a small protein GPCR via library-based screening Dorgham, K. candidate hits from library-based screening so that they can be tested in cell-based assays Akondi, K. small proteins show full in vivo efficacy in a highly stringent model of HIV transmission Steinbach, K.

Sudha K Shenoy et al.

Avrampou, K., et al., RGS4 Maintains Chronic Pain Symptoms in Rodent Models.

Bandekar with help from Nathan Zaidman and Abhishek K. Singh

Eric Trinquet, the scientist behind IP-One, Tag-lite, and now pHSense, challenges conventional scientific From failing fast to embracing serendipity, Eric shares the mindset (and messy origin stories) that shaped

a single sialic acid, although, in rare cases glycans can carry polysialylation (PolySia) (Mindler K

The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility

Eric Trinquet shares in a special Dr.

Eric Trinquet traces how a series of bold pivots—from Cisbio’s HTRF platform to IP-One and now pHSense—reshaped

Addex Provides Corporate Update And Financial Guidance Structure Therapeutics Appoints Industry Leaders Eric

Eric Trinquet and his team at Revvity, that moment came when they watched GPCRs internalize in native

Financial Results And Host Conference Call On August 10, 2023 X4 Pharmaceuticals Closes $115 Million Loan